Full-Time

Senior Scientist

Product Development

Posted on 6/10/2025

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Compensation Overview

$125.3k - $156.6k/yr

Senior, Expert

Company Historically Provides H1B Sponsorship

San Carlos, CA, USA

Category
Bioinformatics
Computational Biology
Genomics
Biology & Biotech
Required Skills
R
Excel/Numbers/Sheets
Requirements
  • BS, MS. or PhD in genetics, molecular biology, biochemistry or a closely related field. PhD with a minimum of 5 years relevant experience, a MS degree and minimum 8 years of relevant experience, or a BS degree and minimum 10 years of relevant experience.
  • Stronge hands-on knowledge of Illumina NGS platforms. Experience with PacBio or Oxford Nanopore is a plus.
  • Proficiency in molecular techniques such as PCR, qPCR, multiplex PCR, digital PCR, NGS, methylation, and target enrichment.
  • Experience developing, validating, and deploying automated workflows in CLIA setting.
  • Familiarity with Design Control and CLIA regulations.
  • Proficient in data analysis tools, such as Excel, JMP, or R.
  • Excellent written and verbal communication skills for documentation, protocol development, and cross-functional team reporting.
  • Detail-oriented, organized, and capable of managing multiple projects in a fast-paced environment.
Responsibilities
  • Drive planning, execution, and analysis of feasibility and optimization studies. Prepare clear and concise study reports in compliance with Natera's guidelines. Present the results and key insights to cross-functional teams at weekly meetings.
  • Collaborate closely with cross-functional teams, such as automation, engineering, R&D, bioinformatics, and lab operations, to develop robust, automated workflows.
  • Lead the integration of automated workflows with digital systems such as LIMS and LabVantage (LV). Support the design and execution of integration testing to ensure data integrity between automation and digital systems.
  • Assist in planning and execution of complex verification and validation studies under design control guidelines.
  • Author and review SOPs, study reports, and transfer documents for production implementation.
  • Train team members on new SOPs and automated workflows.
  • Provide support to lab operations on issues related to automation, including troubleshooting and providing technical guidance.
  • Manage time across multiple experiments and shifting priorities to meet deadlines in fast-paced environment.
  • Communicate project status, key updates, and potential risks clearly to manager and cross-functional teams.
Desired Qualifications
  • Experience with reagent QC development is a plus.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess the health of transplanted organs. Natera also offers tests for family planning and prenatal screening, including the Panorama NIPT, which has conducted over 2 million tests. The company generates revenue through the sale of testing kits and services, often reimbursed by insurance, and provides genetic counseling services for personalized patient support.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Austin, Texas

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for personalized medicine supports Natera's genetic testing services.
  • The global NIPT market is expected to reach $7.3 billion by 2025.
  • Increased adoption of liquid biopsy tests aligns with Natera's cfDNA focus.

What critics are saying

  • Expansion into new Austin space could strain financial resources.
  • Increased competition from companies like Lantheus Holdings threatens market share.
  • HEROES trial for breast cancer may face regulatory hurdles or delays.

What makes Natera unique

  • Natera specializes in cell-free DNA testing for diverse medical applications.
  • Their Signatera test offers personalized ctDNA analysis for cancer patients.
  • Natera's Panorama NIPT has conducted over 2 million non-invasive prenatal tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

5%
PRWeb
May 30th, 2025
The Melanoma Research Foundation To Host The Denver Miles For Melanoma 5K

The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we will be hosting our annual Denver event on Saturday, June 14, 2025 at Sloan Lake Park at 7:30 AM MT. Opening Ceremonies will start at 8:30 AM MT and our race will kick off promptly at 9:00 AM MT. We are excited to share that Kyle Speller, PA Announcer for the Denver Nuggets, will be returning as our emcee on event day! We're also excited to welcome back local sponsor, Cara Mia Dermatology, who will be providing free on-site skin screenings—helping our community stay sun-safe while supporting a great cause.DENVER, May 29, 2025 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we will be hosting our annual Denver event on Saturday, June 14, 2025 at Sloan Lake Park at 7:30 AM MT. Opening Ceremonies will start at 8:30 AM MT and our race will kick off promptly at 9:00 AM MT

Intelligence360
May 15th, 2025
Natera To Spend $9.9 Million To Occupy 30,000 Square Feet Of Space In Austin Texas.

Natera to spend $9.9 Million to occupy 30,000 square feet of space in Austin Texas. Natera to spend $9.9 Million to occupy 30,000 square feet of space in Austin Texas.Austin, Texas — According to state and local development sources, Natera plans to invest $9,900,000.00 to build out 30,000 square feet of new space in Austin. The company plans to occupy the new space at 13011A McCallen Pass in Austin, on or about January 1, 2026. According to the company website Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, womens health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment

TXBN
Apr 24th, 2025
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera(TM) Genome MRD Test

Natera announces broad clinical launch of ultra-sensitive signatera(tm) genome MRD test.

Slater Sentinel
Apr 3rd, 2025
DnB Asset Management AS Invests $235,000 in Natera, Inc. (NASDAQ:NTRA)

DnB Asset Management AS invests $235,000 in Natera, Inc. (NASDAQ:NTRA).

TXBN
Mar 25th, 2025
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

AUSTIN, Texas - (BUSINESS WIRE) - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting on April 29, 2025.